Melanoma and other Skin Tumours
Access ESMO scientific and educational resources on this topic
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Access ESMO scientific and educational resources on this topic
ESMO scientific and educational resources on NSCLC
Access ESMO scientific and educational resources on Upper GI Cancer
Access all ESMO scientific and educational resources on Breast Cancer
Women receiving anthracycline-based treatment for nonmetastatic breast cancer could benefit from the use of cardioprotective agents such as bisoprolol and ramipril
Two years of aromatase inhibitor therapy after initial endocrine treatment provides similar survival outcomes to a 5-year course while reducing the risk of treatment-related bone fracture
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.